MATTHEW STANDRIDGE: Open Payments
NPI 1841371697 · CRAWFORDVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$668 in 27 payments from 14 companies in 2025. Trend: 2023 $406 · 2024 $793 · 2025 $668
Food & beverage: $668
| Company | Payments | Amount |
|---|---|---|
| Organogenesis Inc. | 5 | $225 |
| Smith+Nephew, Inc. | 4 | $95 |
| Kerecis Limited | 5 | $68 |
| ABBVIE INC. | 2 | $50 |
| Novo Nordisk Inc | 2 | $44 |
| Seqirus USA Inc | 1 | $32 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $31 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Exact Sciences Corporation | 1 | $17 |
Products named: APLIGRAF, COLLAGENASE SANTYL, Kerecis SurgiClose, Fluad, JOURNAVX, UBRELVY, TZIELD, Ozempic.
Industry payments across FL — which companies pay providers there.
